Docebo (DCBO) announced that the Toronto Stock Exchange has approved its notice of intention to renew its normal course issuer bid, or NCIB, for its common shares. The renewed NCIB will be made in accordance with the requirements of the Toronto Stock Exchange. Pursuant to the notice, Docebo is authorized to acquire up to a maximum of 1,269,702 Shares, or 5% of the Company’s 25,394,051 issued and outstanding Shares as of May 6, 2026, for cancellation over the next 12 months. The number of Shares that can be purchased pursuant to the NCIB is subject to a current daily maximum of 26,128 Shares, in each case subject to Docebo’s ability to make one block purchase of Shares per calendar week that exceeds such limits. Docebo may begin to purchase Shares on or about May 20, and the bid will terminate on May 19, 2027 or such earlier time as Docebo completes its purchases pursuant to the bid or provides notice of termination. Any Shares purchased under the NCIB will be cancelled upon their purchase. Docebo intends to fund the purchases out of its available cash. In connection with the renewal of the NCIB, Docebo has also renewed its automatic securities purchase plan with its designated broker to facilitate the purchase of Shares under the NCIB at times when Docebo would ordinarily not be permitted to purchase Shares due to regulatory restrictions or self-imposed blackout periods.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo reports Q1 adjusted EPS 35c, consensus 35c
- Docebo sees Q2 revenue $66.7M-$66.9M, consensus $67.05M
- Docebo Files Form 6-K to Furnish Inspire 2026 Investor Briefing and Preliminary Q1 Metrics
- Docebo, Inc. (DCBO) Q1 Earnings Cheat Sheet
- Docebo: Operating Leverage and Long‑Term Profitability Targets Support Undervalued Buy Thesis
